IPO Plus

₹95

▲ +0.44 +0.47%

As of 11 Sept 2026 · delayed

BSE Listed

ESM 1

Aspira Pathlab & Diagnostics Ltd. (540788)

Volume: 1,169Avg Vol 1W: 456Avg Vol 1M: 84652W Range:₹49₹135.88
BSE www.aspiradiagnostics.com AI Report
Key Ratios
Checked 6h ago
Market Cap₹98 Cr
Current Price₹95
Previous Close₹94.56
High / Low (52w)₹135.88 / ₹49
Volume1,169
Avg Vol (1W)456
Avg Vol (1M)846
Stock P/E40.77
Book Value₹7.03
Dividend Yield0%
ROE16.62%
ROA13.75%
Revenue (TTM)—
Revenue Growth—
Profit Margin10.61%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹2.33
P/B13.51
Debt / Equity0.15
50 DMA₹100.2
200 DMA₹81.95
Day change+0.47%
SurveillanceESM 1
Price Chart
₹95▲ 53.60% · 1Y
₹133₹541.4L
2025-09-11
2026-09-11

20-day avg volume: 924 shares

Pros
  • Healthy return on equity of 16.6%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025
Revenue₹3 Cr₹4 Cr₹5 Cr₹6 Cr₹5 Cr₹6 Cr₹5 Cr
EBITDA₹-1 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹1 Cr₹0 Cr
Net Profit₹-1 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹1 Cr₹0 Cr
EPS———————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹5 Cr₹22 Cr₹6 Cr₹5 Cr₹8 Cr₹5 Cr₹7 Cr₹6 Cr
EBITDA₹0 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹-1 Cr₹-1 Cr₹0 Cr
Net Profit₹0 Cr₹2 Cr₹1 Cr₹0 Cr₹2 Cr₹-2 Cr₹-1 Cr₹0 Cr
EPS—1.97——————
Balance Sheet
MetricMar 2024Mar 2025
Total Assets₹15 Cr₹17 Cr
Total Liabilities₹5 Cr₹5 Cr
Equity₹10 Cr₹12 Cr
Total Debt——
Cash Flow
MetricMar 2024Mar 2025
Operating₹1 Cr₹2 Cr
Investing₹0 Cr₹0 Cr
Financing₹-1 Cr₹-1 Cr
Free Cash Flow₹1 Cr₹2 Cr
Shareholding
Promoter 46.58% Institutions 0% Public 53.42%
Efficiency & Working Capital
ROCE13.2%
Interest Coverage6.8
Dividend Payout—
Debtor Days39 d
Inventory Days8 d
Payable Days12 d
Cash Conversion Cycle35 d
Working Capital Days48 d
Shareholding Details

As of 2026-06-30

Promoter46.6%
FII0%
DII0%
Institutions0%
Public53.4%
Promoter Pledge0%
No. of Shareholders1,620
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters18.9%18.9%18.7%18.7%18.5%18.5%18.4%18.4%18.4%18.4%18.4%46.6%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public81.1%81.1%81.3%81.3%81.5%81.5%81.6%81.6%81.6%81.6%81.6%53.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,4061,3511,5121,6951,7061,5931,7411,7701,7551,7841,7691,620
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Arvind Karsandas BhanushaliShareholding of Promoter and Promoter Group13.8%14,19,414
Deepali Arvind BhanushaliShareholding of Promoter and Promoter Group9.4%9,70,943
Aditya AgrawalPublic Shareholding7.4%7,60,921
Jay Arvind BhanushaliShareholding of Promoter and Promoter Group7.2%7,44,465
Nikunj Velji MangeShareholding of Promoter and Promoter Group7.1%7,31,896
Raj Arvind BhanushaliShareholding of Promoter and Promoter Group7%7,17,638
Rajesh Premji BhanushaliPublic Shareholding5.5%5,67,699
Pankaj Jashwant ShahPublic Shareholding4.9%5,00,000
Pooja Rajesh BhanushaliPublic Shareholding3.6%3,70,269
Manas ModiPublic Shareholding3.4%3,45,345
Amit ModiPublic Shareholding2.9%3,00,849
Amit Modi HufPublic Shareholding2.8%2,90,387
Puspahas AgrawalPublic Shareholding2.8%2,88,268
Ram Awtar RamsisariaPublic Shareholding2.4%2,46,715
Manoj RamsisariaPublic Shareholding2%2,05,099
Investeria Financial Services Private LimitedPublic Shareholding1.8%1,85,506
Shradha RamsisariaPublic Shareholding1.5%1,51,566
Shraddha Jagdish BhanushaliShareholding of Promoter and Promoter Group1.5%1,50,262
Saakshi GuptaPublic Shareholding1.4%1,44,387
Paresh Bhanji BhanushaliShareholding of Promoter and Promoter Group0.4%43,999
Ruxmani Jayant BhansaliShareholding of Promoter and Promoter Group0.2%16,200
Yashraj Biotechnology LimitedShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Haseeb A DrabuChairman & Independent Directo2025
Pankaj Jashwant ShahManaging Director & CEO2025
Nikunj MangeManaging Director2025
Manas MengarIndependent Non Exe. Director2025
Krupali ShahCompany Sec. & Compli. Officer2025
Kiran Raghavendra AwasthiAddtnl Independent Director2025
Vaibhav OdhekarAdditional Director & E D2025
Segments — Geography
RegionRevenueShare
India₹22 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10201010
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-12Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000102
2025000000
2025000102
Insider / Designated-Person Trades

8 recent disclosure(s)

Jay Arvind BhanushaliAcquisition · 957
Jay Arvind BhanushaliAcquisition · 623
Jay Arvind BhanushaliAcquisition · 332
Deepali Arvind BhanushaliAcquisition · 85,443
Raj Arvind BhanushaliAcquisition · 6,39,674
Jay Arvind BhanushaliAcquisition · 5,11,738
Substantial Acquisitions (SAST)

4 disclosure(s)

Open Offer08/06/2026 · 22,82,507
Open Offer08/06/2026 · 22,82,507
Open Offer08/06/2026 · 22,82,507
Open Offer08/06/2026 · 22,82,507
Company Information
Incorporated1973
ChairmanHaseeb A Drabu
AuditorSarda Soni Associates LLP
Investor Email[email protected]
🌐 www.aspiradiagnostics.com ↗

📍 Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W), Mumbai, Maharashtra, 400086

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Nippon Life India AMCMahindra LogisticThe New India Assurance CompanyHDFC Life InsuranceSanghvi Brands LimitedSharika Enterprises LimitedDiligent Media CorporationRatnabhumi Developers LimitedMRC Agrotech LimitedDiggi Multitrade LimitedCrystal Business System LimitedAstron Paper & Board Mill Ltd.All “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App